Shanghai HeartCare Medical Technology (HKSE:06609) OCF Margin %: 45.12% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06609 Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
78 GF Score
Price HK$48.24
GF Value HK$54.80
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Shanghai HeartCare Medical Technology OCF Margin %?

Shanghai HeartCare Medical Technology HKSE:06609 -4.29% 78 OCF Margin % is 45.12% as of Dec. 2025. GuruFocus rates HKSE:06609 with a GF Score™ of 78/100 and a GF Value™ of HK$54.80 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Shanghai HeartCare Medical Technology ranks better than 97.42% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Shanghai HeartCare Medical Technology's Cash Flow from Operations for the six months ended in Dec. 2025 was HK$111.0 Mil. Shanghai HeartCare Medical Technology's Revenue for the six months ended in Dec. 2025 was HK$246.1 Mil. Therefore, Shanghai HeartCare Medical Technology's OCF Margin % for the quarter that ended in Dec. 2025 was 45.12%.

As of today, Shanghai HeartCare Medical Technology's current OCF Yield % is 9.17%.

The historical rank and industry rank for Shanghai HeartCare Medical Technology's OCF Margin % or its related term are showing as below:

HKSE:06609' s OCF Margin % Range Over the Past 10 Years
Min: -513.77   Med: -91.9   Max: 37.75
Current: 37.8


During the past 7 years, the highest OCF Margin % of Shanghai HeartCare Medical Technology was 37.75%. The lowest was -513.77%. And the median was -91.90%.

HKSE:06609's OCF Margin % is ranked better than
97.42% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 6.2 vs HKSE:06609: 37.80


Shanghai HeartCare Medical Technology OCF Margin % Related Terms


Shanghai HeartCare Medical Technology OCF Margin % Historical Data

* Premium members only.

The historical data trend for Shanghai HeartCare Medical Technology's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology OCF Margin % Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -228.50 -145.75 -38.05 -1.16 37.75

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.86 6.85 -8.05 28.91 45.12

HKSE:06609 vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's OCF Margin % falls into.


HKSE:06609
78GF Score
Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai HeartCare Medical Technology OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Shanghai HeartCare Medical Technology's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=170.283/451.044
=37.75 %

Shanghai HeartCare Medical Technology's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=111.028/246.093
=45.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 45.12% mean?
Shanghai HeartCare Medical Technology (HKSE:06609) has a OCF Margin % of 45.12% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shanghai HeartCare Medical Technology and its competitors. According to the industry distribution chart, Shanghai HeartCare Medical Technology ranks #21 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 2.6%.
Is Shanghai HeartCare Medical Technology's OCF Margin % too high?
Shanghai HeartCare Medical Technology's current OCF Margin % is 45.12%. The Medical Devices & Instruments industry median OCF Margin % is 6.20. Shanghai HeartCare Medical Technology's value of 45.12% is 627.7% above this industry median. Based on the distribution chart, Shanghai HeartCare Medical Technology ranks #21 out of 813 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai HeartCare Medical Technology ranks #21 out of 813 companies for OCF Margin %. This places Shanghai HeartCare Medical Technology in the top 3% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 6.20. Shanghai HeartCare Medical Technology's value of 45.12% is 627.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai HeartCare Medical Technology's current OCF Margin % of 45.12% is 627.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shanghai HeartCare Medical Technology and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai HeartCare Medical Technology's current OCF Margin % is 45.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.80, compared to a current price of HK$48.24 — trading 12% below its estimated fair value. The current OCF Margin % is 45.12% and 627.7% above the Medical Devices & Instruments industry median of 6.20. Shanghai HeartCare Medical Technology's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current OCF Margin % is 45.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued. The current stock price of HK$48.24 is trading 12% below its estimated GF Value™ of HK$54.80. GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.

Key valuation signals for HKSE:06609:

  • OCF Margin %: 45.12%
  • GF Value™: HK$54.80 vs. price of HK$48.24 (12% below fair value)
  • GF Score™: 78/100 with 2 warning signs
  • Industry Position: 627.7% above the Medical Devices & Instruments median (#21 of 813)

No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai HeartCare Medical Technology Business Description

Address No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
78GF Score

Get the complete analysis for HKSE:06609

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$48.24
Price
HK$54.80
GF Value